课题基金 / 基金详情

MECHANISM-BASED MODELING OF ALPHA-2MU-GLOBULIN ACCUMULATION IN MALE RAT KIDNEY

MECHANISM-BASED MODELING OF ALPHA-2MU-GLOBULIN ACCUMULATION IN MALE RAT KIDNEY
雄性大鼠肾脏中 ALPHA-2MU 球蛋白积累的基于机制的建模
批准号:
6162330
负责人:
R L MELNICK
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

R L MELNICK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Summary of Work: The a2u-globulin hypothesis has been used to discount the human relevance of kidney tumors induced in male rats. We are examining quantitative linkages among critical biological processes in this hypothesis by model simulations using published data. The model includes parameter values that describe the toxicokinetics of the binding ligand, its interaction with a2u-globulin, secretion of a2u-globulin from the liver, resorption of a2u-globulin into proximal tubule epithelial cells, and degradation of the ligand-a2u-globulin complex. A preliminary model of the effects of 2,2,4-trimethylpentan-2-ol (TMP) on the accumulation of a2u-globulin in the male rat kidney showed that this effect cannot be due solely to inhibition of proteolysis. The model suggests that a2u-globulin ligands may increase the hepatic synthesis of this protein and that degradation of unbound a2u-globulin may also be reduced as a consequence of accumulation of the ligand.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BIOAVAILABILITY AND TOXICITY STUDIES OF MICROENCAPSULATED CHEMICALS
MECHANISM OF DI(2-ETHYLHEXYL)PHTHALATE HEPATOTOXICITY
MECHANISM OF DI(2-ETHYLHEXYL)PHTHALATE HEPATOTOXICITY
BIOAVAILABILITY AND TOXICITY STUDIES OF MICROENCAPSULATED CHEMICALS
海外基金